July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (FFR-CT) assessment technology, announced it is merging with Longview Acquisition Corp. II, to become a publicly traded company. Upon completion of the proposed transaction, the combined company will operate as HeartFlow Group Inc.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now